The device failures could lead to increased or decreased values of CO2, which could be fatal, according to a U.S. Food and Drug Administration news release. Additionally, physicians may make clinical decisions based off incorrect displayed values, potentially causing permanent impairment or life-threatening changes.
Currently there have been no reports of injury or death associated with the recalled device, according to the news release.
More articles on recalls:
American Health Packaging recalls oxcarbazepine, ibuprofren for mislabeled packages
Baxter initiates worldwide saline solution recall
Hospira recalls Encore Infusion pumps
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.